Alejandro Llanos-Cuentas Selected Research

Malaria

10/2022	Evidence-Based Malaria Control and Elimination in the Amazon: Input from the International Center of Excellence in Malaria Research Network in Peru and Brazil.
5/2022	Tafenoquine for the treatment of Plasmodium vivax malaria.
1/2021	Time-Varying Effects of Meteorological Variables on Malaria Epidemiology in the Context of Interrupted Control Efforts in the Amazon Rainforest, 2000-2017.
1/2018	Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study.
12/2016	Epidemiology of Plasmodium vivax Malaria in Peru.
6/2016	Accelerating to Zero: Strategies to Eliminate Malaria in the Peruvian Amazon.
10/2015	Genome-Scale Protein Microarray Comparison of Human Antibody Responses in Plasmodium vivax Relapse and Reinfection.
1/2015	Hotspots of Malaria Transmission in the Peruvian Amazon: Rapid Assessment through a Parasitological and Serological Survey.
10/2007	A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru.
9/2007	Polymerase chain reaction detection of Plasmodium vivax and Plasmodium falciparum DNA from stored serum samples: implications for retrospective diagnosis of malaria.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alejandro Llanos-Cuentas Research Topics

Disease

13	Leishmaniasis 01/2023 - 03/2006
13	Cutaneous Leishmaniasis 01/2022 - 02/2005
12	Infections 09/2023 - 09/2007
11	Malaria 10/2022 - 10/2006
10	Vivax Malaria 12/2023 - 03/2014
4	Glucosephosphate Dehydrogenase Deficiency 05/2022 - 01/2015
3	Hemolysis 09/2023 - 01/2015
3	COVID-19 02/2023 - 01/2021
3	Parasitemia 01/2019 - 09/2007
2	Mucocutaneous Leishmaniasis 04/2011 - 06/2007
1	Vomiting 01/2022
1	Strongyloidiasis 05/2020
1	Intestinal helminthiasis 05/2020
1	Helminthiasis (Helminthiases) 01/2018
1	Coinfection 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Reinfection 10/2015
1	Ulcer 01/2015
1	Visceral Leishmaniasis (Kala Azar) 10/2013
1	Body Weight (Weight, Body) 10/2013
1	Wounds and Injuries (Trauma) 01/2012
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2007
1	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2007

Drug/Important Bio-Agent (IBA)

8	tafenoquineIBA 05/2022 - 03/2014
7	Primaquine FDA Link 12/2023 - 02/2016
3	VaccinesIBA 12/2022 - 10/2010
3	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 05/2022 - 01/2015
3	Meglumine AntimoniateIBA 01/2022 - 02/2005
3	Kinetoplast DNA (kDNA)IBA 01/2016 - 04/2011
3	DNA (Deoxyribonucleic Acid)IBA 06/2012 - 09/2007
3	AntimonyIBA 01/2012 - 07/2009
2	EnzymesIBA 01/2022 - 03/2006
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2021
2	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2019 - 01/2016
2	Antimalarials (Antimalarial Agents)IBA 01/2018 - 06/2016
2	Biomarkers (Surrogate Marker)IBA 10/2017 - 01/2016
2	Chloroquine (Aralen)FDA LinkGeneric 03/2016 - 03/2014
2	AntibodiesIBA 01/2015 - 01/2011
2	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 10/2013 - 06/2007
2	Imiquimod (Aldara)FDA LinkGeneric 07/2009 - 06/2007
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2023
1	miltefosine (Impavido)IBA 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2021
1	IsoenzymesIBA 04/2021
1	InsecticidesIBA 01/2021
1	AgarIBA 05/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	CC ChemokinesIBA 01/2018
1	Drug CombinationsIBA 01/2018
1	Dihydroorotate DehydrogenaseIBA 01/2018
1	DSM265IBA 01/2018
1	GoldIBA 12/2016
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 02/2016
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	AntigensIBA 10/2015
1	8-aminoquinolineIBA 01/2015
1	Gentamicins (Gentamicin)FDA LinkGeneric 10/2013
1	Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA 10/2010
1	PolyproteinsIBA 10/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010
1	Interleukin-10 (Interleukin 10)IBA 01/2010
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2010
1	Chemokine ReceptorsIBA 01/2010
1	Chemokine CXCL10IBA 01/2010
1	CXCR3 ReceptorsIBA 01/2010
1	Mefloquine (Lariam)FDA LinkGeneric 10/2007
1	artenimol (dihydroartemisinin)IBA 10/2007
1	ArtesunateIBA 10/2007
1	piperaquineIBA 10/2007
1	Immunologic Factors (Immunomodulators)IBA 10/2006
1	Pentamidine (NebuPent)FDA LinkGeneric 02/2005

Therapy/Procedure

9	Therapeutics 01/2023 - 06/2007
2	Induced Hyperthermia (Thermotherapy) 01/2022 - 01/2013
2	Secondary Prevention 01/2019 - 03/2014
2	Drug Therapy (Chemotherapy) 01/2016 - 06/2007
1	Insecticide-Treated Bednets 10/2022
1	Mass Drug Administration 05/2022
1	Oral Medicine 01/2018
1	Lasers (Laser) 01/2012
1	Injections 10/2010